Legislation roundup: Strategic investment, delisting and pharma

Aug 2, 2018
Requirements for strategic investment in A-share companies are lowered, major violations of the law are specified in the delisting system and MAHs may entrust the sale of pharmaceuticals.
SHARE

Thank you for sharing!

Your article was successfully shared with the contacts you provided.
 

Capital Markets

This premium content is reserved for
China Law & Practice Subscribers.

Benefits Include:

  • Unlimited access to Chinalawandpractice.com site and digital newsletters
  • 5 free articles across the ALM subscription network every 30 days
  • Exclusive discounts on ALM events and publications

Continue reading by getting
started with a subscription.

Subscribe Now For Unlimited Access